Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Qingping Cai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0787-7855; OpenAlex author ID A5101769156. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 3

  1. FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway. Co-author DOI 10.18632/aging.103044↗
  2. MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin β1. Co-author DOI 10.1042/bsr20192358↗
  3. Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer. Last author DOI 10.18632/oncotarget.7397↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dejun Yang · 3 shared papers, 2016–2020 · strength 0.28
  2. Xin Zhang · 1 shared paper, 2020 · strength 0.11
  3. Ronglin Yan · 1 shared paper, 2020 · strength 0.11
  4. Zhenxin Zhu · 1 shared paper, 2019 · strength 0.11
  5. Ziran Wei · 1 shared paper, 2016 · strength 0.06
  6. Yuexiang Wang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.